3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Endometrial Neoplasms
2
Breast Neoplasms
2
TP53 Y220C Mutation
1
Smoking
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Peripheral Nervous System Diseases
1
Overweight
1
Obesity
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Localized Prostate Cancer
1
Leukemia, Myeloid, Acute
1
Infertility
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Genetic Diseases, Inborn
1
Cognitive Dysfunction
1
Interventions
Tamoxifen
7
Specimen Handling
7
exemestane
3
Letrozole
3
Anastrozole
3
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Radiation Dose Hypofractionation
2
Biopsy
2
ruxolitinib
1
poly ICLC
1
fezolinetant
1
elacestrant
1
Testosterone
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Selective Estrogen Receptor Modulators
1
Radiotherapy
1
Radiation
1
Protons
1
Proton Therapy
1
Omacor
1
Neoadjuvant Therapy
1
Multicenter Studies as Topic
1
Metformin
1
Medicare
1
Mastectomy, Segmental
1
Mastectomy
1
Magnetic Resonance Spectroscopy
1
High-Energy Shock Waves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
Tablets
×
90 days
×
Clear all
No trials found.